mAbxience | Leadership Team
mAbxience has a multi-disciplinary team of more than 350 people.
Dr. Sigman and his biochemist wife, Silvia Gold, founded mAbxience in 2009 as the biotechnology arm of Insud Pharma, which the couple set up in 1977.
Hugo Sigman is a trained physician (University of Buenos Aires), specialising in psychiatry. He launched the Research, Development and Innovation Consortium (ID+i) to focus on scientific research some 19 years ago. The Consortium brings together private enterprise and public institutions in Argentina to focus on the research and development of monoclonal antibodies in the search for new cancer treatments.
Since the end of 2013, Hugo Sigman has been president of the Argentine Chamber of Biotechnology (CAB), an organisation that seeks to strengthen the leadership role in biotechnology at a regional level. He also recently joined the YPF Foundation’s Advisory Board as an adviser.
In 2008, Sigman received the Konex Award in the Innovative Entrepreneur category; in 2011, he was recognised by the Asociación de Dirigentes de Empresa (Society of Business Directors – ADE) in the Agro-industry category; and, in 2013, he was selected as Entrepreneur of the Year by the Endeavor Foundation.
His recent speaker appearances include the Experiencia Endeavor event in 2013; the 11th AIDS Symposium, organised by the Huésped Foundation in Buenos Aires, in 2012; the United Nations Conference on Trade and Development (UNCTAD) held in Qatar in 2012 and Geneva in 2011; the 47th IDEA Colloquium in Mar del Plata, Argentina in 2011; and the 15th Conference of the Argentine Industrial Union (UIA) in Buenos Aires in 2009.
Emmanuelle Lepine is mAbxience General Manager. She brings to mAbxience 20 years of experience in the pharmaceutical and biotechnology industry. Emmanuelle is a recognized leader, with hands on experience in establishing and leading successful companies. With her global expertise, Emmanuelle has been supporting organizations to successfully develop, register and launch products on international markets.
Emmanuelle started her career in the pharmaceutical retail sector, to later join the industry in a bioanalytical laboratory at Pharmascience in Canada. During her 12 years at Pharmascience, she was given different leadership roles, first to drive the growth of the International Regulatory Affairs division and later to lead the licensing activities within their global business development unit.
She later spent 5 years with the Alvogen group, where her mandate was to build their biosimilar strategy. Her work led to the creation of Alvotech, where she occupied the position of Deputy CEO. For Alvotech, she supported the company creation, startup activities, business development activities, strategic plan design and execution, as well as being instrumental in supporting all aspects of its first 3 years of growth. In parallel, Emmanuelle was leading her own consultancy company, supporting local and global organizations in the field of Biosimilars.
Emmanuelle holds a Biochemistry degree from University Concordia in Montreal (Canada), as well as a Business degree from the HEC Montreal (Canada) and continued education at Harvard Business School.
mAbxience Argentina Director
Technology Transfer and Process Improvement Director
Global Regulatory Affairs Director
mAbxience León Site Director
Regional Director Latin America
Chief Scientific Officer